Overview

Study in Healthy Volunteers to Assess the Pharmacokinetics of Midazolam Administered Alone and in Combination With Vandetanib

Status:
Completed

Trial end date:
2012-07-01

Target enrollment:

Participant gender:

Summary

The purpose of this study in healthy volunteers is to assess the Pharmacokinetics (PK) of Midazolam administered alone and in combination with Vandetanib.

Phase:

Phase 1

Details

Lead Sponsor:

Sanofi

Treatments:

Midazolam